Почетна › Алцхајмерова болест › Њу Џерзи
Kliničke studije za Алцхајмерова болест u državi Њу Џерзи
25 studija za Алцхајмерова болест traži učesnike na lokacijama u državi Њу Џерзи.
Gradovi u državi Њу Џерзи
Zvanični tekst studije (na engleskom)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1664, Princeton
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06937229A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Global Medical Institutes LLC; Princeton Medical Institute, Princeton
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 6. 11. 2026. · NCT07011732A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- The Cognitive and Research Center of New Jersey - Springfield- Site Number : 8400005, Springfield
Тражи се учесникФаза 2
Узраст од 55 до 85 · Оба пола · Ажурирано 6. 11. 2026. · NCT07688213A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Bio Behavioral Health, Toms River
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 3. 11. 2026. · NCT07011745A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Bio Behavioral Health, Toms River
Тражи се учесникФаза 2
Узраст 55 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06540833A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
Тражи се учесникФаза 1
Узраст од 50 до 85 · Оба пола · Ажурирано 29. 10. 2026. · NCT06297590A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
Тражи се учесникФаза 3
Узраст 55 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07602582A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
Тражи се учесникФаза 3
Узраст од 60 до 85 · Оба пола · Ажурирано 27. 10. 2026. · NCT06976216A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Memory Research Institute - CenExel - PPDS, Toms River
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 27. 10. 2026. · NCT06585787A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- CenExel- AMRI ( Site 1018), Marlton
- The Cognitive and Research Center of New Jersey - Ridgewood ( Site 1064), Ridgewood
- The Cognitive and Research Center of NJ ( Site 1057), Springfield
Тражи се учесникФаза 2
Узраст од 50 до 85 · Оба пола · Ажурирано 20. 10. 2026. · NCT07033494Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- The Cognitive and Research Center of New Jersey, Ridgewood
- The Cognitive and Research Center of New Jersey, Springfield
Тражи се учесникФаза 3
Узраст од 50 до 90 · Оба пола · Ажурирано 19. 10. 2026. · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
Тражи се учесникФаза 3
Узраст од 60 до 85 · Оба пола · Ажурирано 8. 10. 2026. · NCT06976203Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Research - Toms River, Toms River
Тражи се учесникФаза 2
Узраст од 55 до 80 · Оба пола · Ажурирано 7. 10. 2026. · NCT06847321Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0059, Livingston
- Ocean Medical Research, Toms River
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 6. 10. 2026. · NCT06808984Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05048966Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
- Hackensack Medical Center, Hackensack
Тражи се учесник
Узраст од 50 до 100 · Оба пола · Ажурирано 17. 9. 2026. · NCT05295615A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 16. 9. 2026. · NCT07821658Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Rutgers-Robert Wood Johnson Medical School, New Brunswick
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 8. 2026. · NCT06563895A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- CenExel-HRI, Marlton
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 45 до 85 · Оба пола · Ажурирано 4. 6. 2026. · NCT06657768A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
Тражи се учесникОпсервациона студија
Узраст 19 и старији · Оба пола · Ажурирано 21. 4. 2026. · NCT06810960Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст од 18 до 120 · Оба пола · Ажурирано 13. 4. 2026. · NCT07012993Exercise to Improve Brain Health in Older African Americans
- Rutgers, The State University of New Jersey - Newark campus, Newark
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст 60 и старији · Оба пола · Ажурирано 20. 2. 2026. · NCT05597124ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
- Rutgers - Institute for Health, New Brunswick
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст 60 и старији · Оба пола · Ажурирано 6. 2. 2026. · NCT07392723Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
Тражи се учесникФаза 2
Узраст од 50 до 85 · Оба пола · Ажурирано 2. 2. 2026. · NCT07105709Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.